Article info
Clinical science
Clinical and pathological risk factors for worse stage and mortality of eyelid and periocular squamous cell carcinoma
- Correspondence to Dr Renbing Jia, Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China; renbingjia{at}sjtu.edu.cn; Dr Yefei Wang; paper34{at}163.com; Dr Shiqiong Xu; 215769592{at}qq.com
Citation
Clinical and pathological risk factors for worse stage and mortality of eyelid and periocular squamous cell carcinoma
Publication history
- Received July 27, 2020
- Revised March 30, 2021
- Accepted April 3, 2021
- First published April 20, 2021.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.